Detalles de la búsqueda
1.
The soluble cytoplasmic tail of CD45 regulates T-cell activation via TLR4 signaling.
Eur J Immunol
; 51(12): 3176-3185, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34626426
2.
A new approach to a Lyme disease vaccine.
Clin Infect Dis
; 52 Suppl 3: s266-70, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21217174
3.
Modulation of the liver immune microenvironment by the adeno-associated virus serotype 8 gene therapy vector.
Mol Ther Methods Clin Dev
; 20: 95-108, 2021 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33376758
4.
Nonreplicating vaccinia virus vectors expressing the H5 influenza virus hemagglutinin produced in modified Vero cells induce robust protection.
J Virol
; 83(10): 5192-203, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19279103
5.
GATA-1, G208S macrothrombocytes are deficient in talin: immunofluorescence studies.
Platelets
; 20(3): 216-24, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19437340
6.
Immunogenicity and protective efficacy of a Vero cell culture-derived whole-virus H7N9 vaccine in mice and guinea pigs.
PLoS One
; 10(2): e0113963, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25719901
7.
Laboratory diagnosis of Lyme neuroborreliosis is influenced by the test used: comparison of two ELISAs, immunoblot and CXCL13 testing.
J Neurol Sci
; 347(1-2): 96-103, 2014 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25288328
8.
MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 viruses.
PLoS One
; 9(2): e88340, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24523886
9.
Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patients.
Clin Vaccine Immunol
; 21(6): 867-76, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24739978
10.
A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato.
Clin Vaccine Immunol
; 21(11): 1490-9, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25185574
11.
Evaluation of OspA vaccination-induced serological correlates of protection against Lyme borreliosis in a mouse model.
PLoS One
; 8(11): e79022, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24260146
12.
Preclinical evaluation of Vaxfectin-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccines.
Hum Vaccin Immunother
; 9(6): 1333-45, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23857272
13.
Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial.
Lancet Infect Dis
; 13(8): 680-9, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23665341
14.
A cell culture-derived whole-virus H5N1 vaccine induces long-lasting cross-clade protective immunity in mice which is augmented by a homologous or heterologous booster vaccination.
Vaccine
; 30(37): 5533-40, 2012 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22749797
15.
Pre-clinical efficacy and safety of experimental vaccines based on non-replicating vaccinia vectors against yellow fever.
PLoS One
; 6(9): e24505, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21931732
16.
Vectors based on modified vaccinia Ankara expressing influenza H5N1 hemagglutinin induce substantial cross-clade protective immunity.
PLoS One
; 6(1): e16247, 2011 Jan 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-21283631
17.
Seasonal influenza vaccine elicits heterosubtypic immunity against H5N1 that can be further boosted by H5N1 vaccination.
Vaccine
; 28(7): 1778-85, 2010 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-20018265
18.
A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations.
PLoS One
; 5(8): e12217, 2010 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-20808939
19.
Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans.
Vaccine
; 29(2): 166-73, 2010 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-21055500
20.
A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.
PLoS One
; 5(2): e9349, 2010 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-20186321